Sweden · Funded startup

Who invested in Modus Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$3.0Mraised across 1 round since 2025, from 1 source

Latest round
Round, $3.0MJun 2025
Investors
0
See who backed them

The rounds

  1. Jun 2025
    Round$3.0M

    No investor was named in the report.

    Source recorded

Founders and team

From Modus Therapeutics's own website: 3 on the team.

  • Claes LindbladCFO & Head of IR
  • Pernilla SandwallBoard Member | COO of Umecrine Cognition AB
  • Sofi ErikssonBoard Member since May 2026.

Quick answers about Modus Therapeutics

How much has Modus Therapeutics raised?

Modus Therapeutics has raised $3.0M across 1 round since 2025.

When did Modus Therapeutics last raise?

Modus Therapeutics's most recent round was an Undisclosed round of $3.0M in Jun 2025.

What was Modus Therapeutics's biggest round?

Its most recent round, $3.0M in Jun 2025, is also its largest on record.

What stage is Modus Therapeutics at?

Modus Therapeutics's latest named round is an Undisclosed round, in Jun 2025.

Where is Modus Therapeutics based?

Modus Therapeutics is based in Sweden.

Companies like Modus Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.